44
Participants
Start Date
July 15, 2024
Primary Completion Date
October 15, 2027
Study Completion Date
October 15, 2027
Irinotecan Hydrochloride Liposome Injection
At the dose of 70mg / m2, for patients homozygous for UGT1A1 \* 28, the first dose of irinotecan was adjusted to 50mg / m2,70mg / m2 if the patient tolerated during the first cycle and 70 mg / m 2 in the subsequent cycle; add 500 mL of 5% glucose injection or 0.9% sodium chloride injection for intravenous infusion within 90 minutes. On the first day of each treatment cycle.
First Affiliated Hospital of Xian Jiaotong University, Xi'an
First Affiliated Hospital Xi'an Jiaotong University
OTHER